Recent surveys by the Psoriasis Association of Malaysia have identified critical gaps in insurance coverage for chronic diseases, highlighting structural challenges in health financing. Coverage for outpatient consultations, long-term medication, and biologic therapies remains variable across policies, resulting in substantial out-of-pocket expenses even for insured patients. This variability may lead to waiting periods, premium adjustments, policy exclusions, or limitations on coverage, particularly for newly diagnosed individuals. The findings reflect a broader reality that many insurance systems have historically been designed around short-term, hospital-based care, while chronic diseases require continuous outpatient management and long-term therapeutic support.
As reported by Mint, hiring a certified home nurse in a metropolitan area represents a massive monthly outlay on its own. When combined with mobility rentals, oxygen infrastructure, diagnostic screenings, and daily therapy sessions, the financial drain persists long after primary insurance claims close. Families frequently underestimate long-term care costs because hospitalisation is viewed as the primary battle. Once a loved one returns home, there is a psychological assumption that the crisis has passed, but protracted recoveries quietly erode household savings for months. Indian households often see family members reduce working hours or exit the workforce entirely to manage caregiving duties, introducing heavy indirect financial strain alongside direct medical bills.
According to Mint, in response to changing consumer needs following the pandemic, insurers have expanded home healthcare provisions. Many contemporary policies now compensate for domiciliary care, home nursing, oxygen setups, and specialised post-hospital therapies. However, the fine print remains a critical barrier, with benefits rarely open-ended and strictly bound by post-discharge timelines. Some policies restrict post-hospital claims strictly to medicines and diagnostics, excluding active nursing or physical therapy. Consequently, two plans featuring identical headline coverage limits can perform entirely differently during prolonged recovery periods. The recent Malaysian survey found variations in underwriting approaches across the market, suggesting that more consistent and structured solutions may be possible.
As reported by Mint, financial experts urge buyers to look beyond basic sum insured, as the quality of convalescence coverage dictates long-term financial survival. Before a crisis hits, policyholders should review their policy clauses carefully to avoid discovering gaps when it is too late. Key considerations include confirming post-hospital timelines, checking if home healthcare requires explicit prior authorization from insurers, and maintaining emergency buffers to bridge gaps when insurance limits inevitably expire. The Malaysian survey suggests potential approaches including structured chronic disease benefit riders, tiered coverage models based on disease severity, co-payment arrangements, defined caps for high-cost therapies, and public-private partnership models for advanced treatments. Strengthening national data systems on treatment outcomes and continued dialogue among stakeholders is essential for improving access while ensuring sustainability.
